XML 54 R22.htm IDEA: XBRL DOCUMENT v3.20.1
STOCK-BASED COMPENSATION PLANS (Tables)
3 Months Ended
Mar. 31, 2020
STOCK-BASED COMPENSATION PLANS  
Schedule of outstanding and exercisable number of options

 

 

 

 

 

 

 

    

Outstanding

    

Exercisable

 

 

Number of Options

 

Number of Options

 

 

(in thousands)

 

(in thousands)

Plan Category

 

  

 

 

  

2005 Stock Option Plan

 

388

 

 

388

Equity Compensation Plans not approved by  Shareholders

 

59

 

 

30

2017 Stock Option Plan

 

869

 

 

238

Total

 

1,316

 

$

656

 

Schedule of share based compensation expenses recorded in the consolidated statement of income

The following summarizes stock-based compensation expenses recorded in the consolidated statements of operations:

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended March 31,

 

    

2020

    

2019

Cost of Revenue

 

$

 6

 

$

 6

Sales and marketing expense

 

 

29

 

 

41

General, and administrative

 

 

462

 

 

93

Total stock based compensation expense

 

$

497

 

$

140

 

Fair Value of Stock Options Grants

The Company used the Black-Scholes option pricing model to determine the fair value of stock option grants, using the following assumptions for the three months ended March 31, 2020 and March 31, 2019.

 

 

 

 

 

 

 

 

 

For the Three Months

 

 

 

Ended March 31, 

 

 

    

2020

 

2019

 

Expected term (years)

 

6.79

 

6.25

 

Risk-free interest rate

 

1.59

%

2.62

%

Expected volatility

 

116.76

%

121.98

%

Expected dividend yield

 

 —

%

 —

%

 

Summary of Stock Option Activity Under the Option Plan

A summary of stock option activity under all equity compensation plans for the three months ended March 31, 2020, is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

Aggregate

 

 

Number of

 

Average

 

Contractual

 

Intrinsic

 

 

Shares

 

Exercise

 

Term

 

Value

 

    

(in thousands)

    

Price

    

(Years)

    

(in thousands)

Outstanding at December 31, 2019

 

1,855

 

$

2.48

 

6.42

 

$

10,032

Granted

 

14

 

$

10.15

 

  

 

 

  

Forfeited

 

(175)

 

$

5.40

 

  

 

 

  

Exercised

 

(378)

 

$

0.58

 

  

 

 

  

Outstanding at March 31, 2020

 

1,316

 

$

2.72

 

7.18

 

$

10,991

 

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2020

 

656

 

$

1.00

 

5.81

 

$

6,604

 

Restricted Stock Award Activity Under all Equity Compensation Plans

A summary of restricted stock award activity under all equity compensation plans for the three months ended March 31, 2019, is presented below:

 

 

 

 

 

 

Number of

 

 

Shares

 

    

(in thousands)

Granted but not vested at December 31, 2019

 

102

Granted

 

165

Vested

 

(7)

Granted but not vested at March 31, 2020

 

260